Ophthalmologic Examinations After Infusion of ZK200775

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 1996

Primary Completion Date

April 30, 1998

Study Completion Date

April 30, 1998

Conditions
Visual Acuity
Interventions
DRUG

ZK200775

Intravenous infusion of 0.3 mg/kg/h of ZK200775 over a period of 4 hours.

DRUG

ZK200775

Intravenous infusion of 0.75 mg/kg/h of ZK200775 over a period of 4 hours.

DRUG

Sodium Chloride

Intravenous infusion of sodium chloride over a period of 4 hours.

Trial Locations (1)

13353

Charité Unviversitätsmedizin Berlin, Augenklinik Campus Virchow-Klinikum, Berlin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER

NCT00999284 - Ophthalmologic Examinations After Infusion of ZK200775 | Biotech Hunter | Biotech Hunter